RNS Number : 7501Z
easyJet PLC
21 May 2019
 

easyJet plc ("the Company")

 

Director/PDMR shareholding

21 May 2019

The Company announces that on 20 May 2019, the Restricted Share Awards of 35,647 Ordinary Shares granted to Garry Wilson, CEO easyJet Holidays under the LTIP Restricted Share Plan, which vested on 12th May were sold in their entirety.

Set out below are the notifications, made in accordance with the requirements of the EU Market Abuse Regulation, in relation to the LTIP.

 

For further details, please contact:

 

Stuart Morgan, Investor Relations

07989 665484

Flic Howard-Allen, Corporate Communications

07977 402036

Anna Knowles, Corporate Communications

07985 873313



1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Garry Wilson

 

2.

Reason for the notification

a)

Position/status

CEO, easyJet Holidays

b)

Initial notification/ Amendment

This is an initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

easyJet plc

b)

LEI

2138001S47XKWIB7TH90

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary share of 27 2/7p

 

 

 

ISIN: GB00B7KR2P84

b)

Nature of the transaction

Sale of Restricted Share Awards of 35,647 Ordinary Shares under LTIP Restricted Share Plan

 

c)

Price(s) and volume(s)


Price(s)

Volume(s)

Restricted Share Awards

£9.966

35,647

d)

Aggregated information

 

Aggregated volume

Price

 

Aggregated volume: 35,647

 

GBP 355240.18

e)

Date of the transaction

2019-05-20

f)

Place of the transaction

XLON

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHKMGZKDMNGLZM